Every imaging technique in Cardiology aims at a complete visualization and comprehensive assessment of cardiac morphology and pathology as the heart is a complex geometric structure. Therefore, analysis of the heart in motion in all three or four (including time) dimensions can further facilitate and enhance the diagnostic capabilities of echocardiography. The 3-dimensional echocardiography is still in its evolution and at the phase of early adaptation with respect to its clinical application. It should complement current echocardiographic techniques by providing better understanding of the topographical aspects of pathology and refined definition of the spatial relationships of (intra) cardiac structures. Furthermore, it provides new indices not described previously by 2-dimensional echocardiography and makes the existing ones more accurate. The assessment of patients with mitral valve disease is one of the most challenging as well as promising clinical applications of 3-dimensional echocardiography 17 .
Two-dimensional echocardiography plays a key role in selecting the most appropriate therapeutic strategy in patients with mitral stenosis 17 . Apart from estimation of the transmitral pressure gradient, two-dimensional echocardiography can calculate mitral valve area by planimetry and pressure half-time (Robiolio et al 1998) . Also, two-dimensional echocardiography is essential in the selection of patients for percutaneous mitral valvuloplasty (PMV) 26 . Among all available mitral valve scoring systems, Wilkins's score is the most commonly used 18 . This score evaluate mitral valve thickness, mobility, leaflet calcification, and the degree of subvalvular apparatus thickening and shortening / changes 19 . A favourable Wilkins's score(<8points) is highly predictive of a good outcome after PTMC 18 . More recently it has been shown that other factors, such as commissural fusion and calcification, are also strong predictors of outcomes after PTMC 28 .
The introduction of real-time three-dimensional echocardiography and advances in analysis software have improved mitral orientation and evaluation. Several studies have reported improved accuracy and superiority of realtime three-dimensional echocardiography over twodimensional echocardiography for mitral valve area estimation 8, 12, 25 . Real-time three-dimensional echocardiography allows a unique "en face" view and morphologic analysis of the entire mitral valve apparatus, including the mitral valve annulus, the subvalvular apparatus, and its anatomic relation to other nearby structures. In the current study it is aimed to assess a new real-time three-dimensional echocardiography score for the assessment of the mitral valve in patients with mitral stenosis in comparison with Wilkins's score for the prediction of PTMC outcomes.
Methods:
This cross-sectional analytical study was conducted in the University Cardiac centre, BSMMU from December 2012 to May, 2014. A total of 50 patients were enrolled in the study. Detailed history, clinical examination and relevant investigation reports of all patients were recorded in pre-designed data collection sheet at the beginning of the study. Patients who were suspected or diagnosed as a case of chronic rheumatic heart disease in the form of mitral stenosis and were already enrolled for transthoracic Doppler echocardiography in BSMMU (both in patients and out patients) for further evaluation were selected to include in the study. Among these patients who had proven mitral stenosis by means of 2-D echo with suitable morphology for PTMC and consented for doing PTMC and taking part in the study were selected as a case. At first 2-D Wilkins' score was done. RT3DE score was done in the same setting. After PTMC outcome was assessed by means of 2-D and 3D echo on the basis of MVA, MR grade and commissural splitting. After collection of data they were edited and summarized and then analyzed and interpreted. Data were processed and analyzed by using computer software SPSS 16 (Statistical package for social sciences version 16). Categorical data was expressed in percentage or number. Parametric data was expressed in mean + SD. Categorical data was evaluated by Chi square and Fisher's Exact test. Significance was defined as p value < 0.05. Kappa statistic was calculated as a measure of agreement between 2D and 3D echocardiography.
Results:
Amongst 50 patients included in our study, there were no deaths or any complications, with the exception of worsening MR that was associated with PTMC. Among 50 patients that took part in the study 26(52%) were in the 31-40year age group, 19(38%) in the 20-30 year age group and 5 (10%) in the >40 year age group. 39 (78%) patients were female. So this study showed a preponderance of mitral stenosis in 31-40 year aged females ( Table-I Table-II) . Post PTMC echocardiography showed there were partial commissural splitting in 11 patients (22%) and complete commissural splitting in 39 patients (78%) ( Table-III) . Prior to PTMC no patient in this study had more than mild MR and mostly had no MR. Post PTMC echocardiography showed that in 5 patients(10%) there were no or trivial MR, and in 30(60%) patients had mild, 10(20%) patients had moderate, and 5(10%) had severe MR (Table-IV) . Outcome is assessed post procedure on the basis of achieved mitral valve area, MR grade and commissural splitting. Taking into account these three parameters total 35 patients (70%) had optimal outcome and 15 patients (30%) had suboptimal outcome ( Table-V) . That is, 66% of the 'mild group' patients had optimal and 34% had sub-optimal outcome. And, 76% of the 'moderate group' patients had optimal and 24% had sub-optimal outcome. So, percentage wise 'moderate group' patients had relatively better outcome than the 'mild group'. But the difference in outcome in different groups is not statistically significant (P>0.05) (Table VI) . 
76.
All 10 patients of 'mild group' (according to RT3DE score), 24 patients out of 28 'moderate group' patients and 1 patient out of 10 'severe group' had optimal outcome. That is, 100% of the 'mild group' patients, 86% of the 'moderate group' patients and 8.3% of the 'severe group' had optimal outcome. So, percentage wise there was a gradual fall of success rate from mild to severe group. Again, the difference in outcome in different groups was statistically significant (P<0.05) (Table VII) . The strength of agreement between 2-D and 3-D echo are found to be 'poor'(ê-0.04) and so the difference between 2-D and 3-D scoring system in categorizing MS patients was statistically significant (P<0.05) (Table VIII & II) . One of the most significant developments of the last decade in echocardiographic imaging of the heart was the evolution of 3-dimensional (3D) imaging from slow and labor-intense offline reconstruction to real-time volumetric imaging. This imaging modality provides valuable clinical information that empowers echocardiographers with new levels of confidence in the diagnosis of heart disease 11,14 previously described the technological milestones in the development of real-time 3D echocardiographic (RT3DE) imaging and its major advantages over conventional 2-dimensional echocardiography (2DE) and reviewed the published literature that supported the use of this new methodology in clinical practice. Since 2006, the growing availability of RT3DE technology, its ease of use, and its multiple attractive features have sparked significant interest in the research community, resulting in a large number of publications, most of which have endorsed RT3DE imaging for clinical use by demonstrating its unique capabilities in different scenarios. In parallel, the clinical acceptance of this new tool has broadened significantly. The most recent clinically significant addition is matrixarray transoesophageal echocardiography (TEE), which provides images of unprecedented quality that aid surgeons and interventional cardiologists in planning and guiding procedures and evaluating their outcomes 14 .
The purpose of the present study was to determine and compare the 2D & 3D echocardiographic assessment of MV apparatus in patients with rheumatic MS and thereby predict the outcome after PTMC.
This study included 50 patients, 78% of them were female. This fact of female predominance is similar to what was mentioned in some studies from south Asia, the Middle East and North Africa 21 . Girls and women, in particular, seem to be severely affected possibly as a result of being housebound and having to live in overcrowded conditions 16 . The majority of patients belonged to the age group 31-40 years. This can be explained by the fact that the first attack of rheumatic fever usually occurs at the age of 20 to 30 years 2, 5, 20 .
.Amongst 50 patients included in this study, there were neither any death nor any major complication, excepting worsening of MR associated with PTMC. Using 3-D echocardiography in future studies may provide more accurate parameters for the prediction of the PTMC result since this method provides a unique en face view and morphologic analysis of the entire mitral valve apparatus 3 and it is superior for the evaluation of leaflet mobility and commissures 24 . The echocardiographic examination aids clinicians to predict overall PTMC success. Successful PTMC results are influenced by patients' age, LA size, and mitral valve thickness.
Again analyzing the study result it is evident that Wilkins' score, although validated for quite some time for pre-PTMC assessment, is not a hundred percent perfect tool. So, useful addition can be made to it. It is shown in this study that it failed to pin point those cases as 'severe' that were 'severe' according to RT3DE score and group wise these patients had mostly suboptimal outcome. Another key point that should provide food for thought was the better outcome rate amongst the 'moderate' group rather than the 'mild' group. Although small sample size could be the reason for this inconsistency, still, it is too characteristic a point to ignore. By analysis of the data of current study it is found that there was 'poor' agreement between 2-D and 3-D echo and the difference is statistically significant. That is why, if 3-D echo is added as a routine assessment tool with the conventional 2-D echo it would bring a new dimension that is likely to be more accurate and as a result will benefit the patients, the prime goal of any treatment, as also will exhaust the valuable and scanty resources more efficiently and amicably.
Conclusion:
3-D echocardiography was more accurate and consistent than 2-D echocardiography in assessing outcome of PTMC. But in this study outcome of PTMC was assessed immediately after the procedure; so it is not prudent to comment straight way that this prediction is also wellsuited for long term outcome assessment. Moreover, the small sample size could be the cause of some inconsistencies of the 2-D echo findings and can also overestimate or underestimate the benefits of 3-D echo as an assessment tool. In this regard further studies can be done to establish a workable 3-D score for routine clinical use. Again, there is provision to do further studies on 3-D scoring incorporating some other demographic, echocardiographic and technique related parameters. Dreams that inflict desire in the right use of resources and pursuation in cherishing and nurturing expertise could bring about the right changes that take the dormant 'wishes and desires' in the core of a scientific mind to a new height. We live in the realm of science, but we dream of a 'fiction' that will once be 'the scientific fact' so there is no end in the walk of 'science' towards glory; this study is only a step, no doubt, there are many more to come in this particular field of applied medicine. 
